Use and Costs of Sentinel Lymph Node Biopsy in Non-Ulcerated T1b Melanoma: Analysis of a Population-Based Registry.
Joshua N HerbDavid W OllilaKaryn B StitzenbergMichael O MeyersPublished in: Annals of surgical oncology (2021)
In this population-based study, only 4% of selected non-ulcerated T1b patients had a positive SLNB, which is lower than prior reports. At the population level, SLNB is associated with high costs per prognostic information gained.